Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
Advertisement

PTHvsBBPETF Comparison

ETF 1
PTH

Invesco DWA Healthcare Momentum ETF

This fund is part of
US Health Care
-0.03%
VS
ETF 2
BBP

Virtus LifeSci Biotech Products ETF

This fund is part of
Tomorrow's Treatments
-0.9%

Invesco DWA Healthcare Momentum ETF (PTH) belongs to the US Health Care segment. Virtus LifeSci Biotech Products ETF (BBP) is part of the Tomorrow's Treatments segment. Both ETFs have the same top 3 sector exposures: and Health Care. PTH is less expensive with a Total Expense Ratio (TER) of 0.72%, versus 0.79% for BBP. PTH is up 1.75% year-to-date (YTD) with -$6M in YTD flows. BBP performs better with 5.08% YTD performance, and +$12M in YTD flows. Run a side-by-side ETF comparison of PTH and BBP below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

PTH vs BBP performance and flow charts

Performance

051015%Mar 27Apr 6Apr 13Apr 20Apr 27

Cumulative Flows

0 M2 M4 M6 M8 MMar 27Apr 6Apr 13Apr 20Apr 27

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 04/28/2026
1M3MYTD1Y3Y5Y
Perf.
PTH
BBP
+8.86%+6.43%
+4.25%+0.15%
+1.75%+5.08%
+32.72%+45.43%
+30.38%+65.96%
-2.01%+54.57%
Flows
PTH
BBP
-$498K+$8M
-$5M+$12M
-$6M+$12M
-$10M+$24M
-$80M+$27M
-$357M+$17M
Volatility and drawdown
3M1Y3Y5Y
Volatility
PTH
BBP
+27.25%+28.48%
+23.02%+24.06%
+24.62%+23.77%
+25.29%+26.18%
Max drawdown
PTH
BBP
-7.51%-9.59%
-11.91%-9.81%
-29.24%-25.54%
-50.10%-38.24%
Max drawdown duration
PTH
BBP
40d48d
140d36d
271d292d
1699d915d
Trading data

Create an account to view trading data

Join for free
PTH
BBP
Last sale
4/28/2026 at 1:30 PM
$50.57
$82.82
Previous close
04/28/2026
$52.10
$83.51
Consolidated volume
04/28/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of March 31, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

Create an account to view replication quality

Join for free
PTH
BBP
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 4/28/2026 at 1:30 PM
Live
Closed
PTH
BBP
Last price
$50.57
$82.82
1D performance
-2.93%
-0.83%
AuM$121.40 M$58.67 M
E/R0.72%0.79%
Characteristics
PTH
BBP
Management strategyPassivePassive
ProviderInvescoVIRTUS Investment Partners
BenchmarkDorsey Wright Healthcare Technical Leaders IndexLifeSci Biotechnology Products Index
N° of holdings4656
Asset classEquitiesEquities
Trailing 12m distribution yield
Join
Join
Inception dateOctober 12, 2006December 16, 2014
ESGNoNo
Advertisement
Exposure

Countries

PTH
USA
94.53%
Other
5.47%
BBP
USA
89.45%
Other
10.55%

Sectors

PTH
Health Care
85.2%
Other
14.8%
BBP
Health Care
88.78%
Other
11.22%
Advertisement

Diversification

PTH

Total weight of top 15 holdings out of 15

52.67%
BBP

Total weight of top 15 holdings out of 15

33.42%

Top 15 holdings

Data as of March 31, 2026
PTH
TERNS PHARMACEUTICALS
6.73%
ROIVANT SCIENCES LTD
5.47%
US74006W2070
5.15%
ARROWHEAD PHARMACEUTICALS INC
3.66%
GUARDANT HEALTH INC
3.47%
REVOLUTION MEDICINES INC
3.32%
TENET HEALTHCARE
3.16%
UTD THERAPEUT
2.99%
NATERA
2.95%
HCA HEALTHCARE
2.89%
CELCUITY INC
2.88%
AXSOME THERA CMN STK
2.58%
MADRIGAL PHARMACEUTICALS INC
2.58%
PROTAGONIST THERAPEUTICS INC
2.43%
COGENT BIOSCIENCES
2.40%
BBP
BIOCRYST PHARMACEUTICALS
2.50%
ROIVANT SCIENCES LTD
2.45%
SYNDAX PHARMACEUTICALS INC
2.40%
GILEAD SCIENCES
2.25%
GERON
2.24%
GB00BRXB0C07
2.23%
KALVISTA PHARMACEUTICALS INC
2.22%
AMGEN-T
2.20%
AXSOME THERA CMN STK
2.20%
AGIOS PHARMA/D
2.18%
BIOGEN INC
2.17%
UTD THERAPEUT
2.13%
LIGAND PHARMACEUTICALS
2.13%
BIOMARIN PHARMACEUTICAL
2.06%
EXELIXIS
2.05%
Frequently asked questions about PTH and BBP

How have the PTH and BBP ETFs performed in 2026?

As of April 28, 2026, PTH is up 1.75% year-to-date (YTD), while BBP has returned 5.08%. That puts BBP better performer ahead so far this year.

Which ETF is attracting more investor money: PTH or BBP?

Year-to-date, the PTH ETF saw -$6M in flows, compared to +$12M for BBP.

Which ETF is more volatile: PTH or BBP?

Over the past year, PTH had a volatility of 23.02%, while BBP experienced 24.06%.

Which ETF is bigger: PTH or BBP?

As of April 28, 2026, PTH holds $121.40 M in assets under management (AUM), while BBP manages $58.67 M.

What sectors do the PTH and BBP ETFs invest in?

PTH leans toward sectors like Health Care. Meanwhile, BBP focuses on Health Care.

What are the top holdings of the PTH ETF and BBP ETF?

PTH top holdings include TERNS PHARMACEUTICALS, ROIVANT SCIENCES LTD and US74006W2070. BBP holds in its top three: BIOCRYST PHARMACEUTICALS, ROIVANT SCIENCES LTD and SYNDAX PHARMACEUTICALS INC.

Which ETF is more diversified: PTH or BBP?

PTH holds 57 securities with 52.67% of its assets in the top 15. BBP has 61 securities and a top 15 weight of 33.42%.

Advertisement
Latest news about PTH & BBP
Advertisement
Advertisement
Advertisement
ETF INVESTOR RESOURCES

Expert-Built ETF Portfolios, All in One Place

Don’t start from scratch. Discover ready-made ETF portfolios built by professionals to match different goals, timelines, and market views. Use them as inspiration or as a starting point for your own allocation.

Portfolio Builder